Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuromuscular
How do you use serum IgG levels when treating with FcRN inhibitors?
Related to
previous question on dosing of rozanolixizumab
Related Questions
What is your approach to patients with diffuse, patchy paresthesias affecting the head, face, lips, and/or tongue?
How do you decide between the gene silencing drugs for familial amyloidosis with polyneuropathy?
How do you decide when to add steroid-sparing immunotherapy for myasthenia gravis after starting prednisone and Mestinon?
How could you utilize neuromuscular ultrasound as a marker of disease progression/treatment response in CIDP?
In which clinical scenarios do you find medial and lateral plantar sensory or mixed nerve conduction studies to be valuable?
Do you routinely perform muscle biopsies in patients presenting with the classic symptoms of Inclusion Body Myositis along with positive CN1A antibody?
When do you use rozanolixizumab for Musk MG?
Do you always biopsy patients who present with classic skin findings of dermatomyositis?
When and how do you perform genetic testing for congenital myasthenia gravis in seronegative cases?
Which non-pharmacologic treatments for neuropathic pain have you found most effective?
